Intractable Pain

Pain·MeSH: Pain, Intractable

3 drugs in development·3 companies·1 clinical trial

Drug Pipeline by Phase

Phase 2(1)

Drug	Company
resiniferatoxin	Sorrento Therapeutics, Inc. (SRNE)

Phase 1(2)

Drug	Company
intrathecal resiniferatoxin	National Research Corporation Common Stock (Delaware) (NRC)
intrathecal resiniferatoxin	GH Research PLC (GHRS)

BioSniper tracks 3 drugs in development for Intractable Pain across 3 companies.

There are 1 clinical trial targeting Intractable Pain tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.